RHOJ and neoplasm: On the other hand, Rhoj, a small Rho GTPase, is known to act as a crucial regulator, promoting resistance to a wide range of chemotherapeutic agents in epithelial-to-mesenchymal transition (EMT) of tumor cells [51].